-
Presentations at the AIDS 2014 conference offer differing outlooks on increased risk of HIV in women using contraceptive injections.
-
Long-acting reversible contraception (LARC) — the copper T and levonorgestrel intrauterine devices (IUDs) and the birth control implant — are the most effective reversible methods available to prevent unintended pregnancy. They last for several years and are easy to use. Clinicians can draw lessons from the Contraceptive CHOICE project in St. Louis on how to make their clinics "LARC First.
-
-
With the introduction of genetic testing that is increasingly affordable, more patients are approaching their health care providers about such testing or with results from their direct-to-consumer genetic tests. Research findings linking MTHFR gene polymorphisms and disease risk have been conflicting. This has led to challenges as far as interpreting such data.
-
Angiogenesis is an important process, which sustains ovarian cancer growth. Cediranib, a potent, oral tyrosine kinase inhibitor (TKI) of vascular endothelial growth factor receptor (VEGFR) 1, 2, and 3, and c-kit, has shown promise in other solid tumors, including non-small cell lung cancer.
-
-
In this issue: Statin and niacin increase HDL-C, omeprazole reduces effectiveness of clopidogrel, darbe-poetin increases risk of stroke, statins decrease risk of gallstone disease, FDA Actions.
-
-
Based on results of two systematic evidence reviews, the USPSTF issued a revised statement regarding recommendations for breast cancer screening.
-
Three to 5% of patients at term will have breech presentations, and in most countries 90% of these patients will be delivered by Cesarean section.
